Dear faculty, staff and learners,
I am pleased to share with you the good news that our Medical School is fully accredited and compliant with each of the 12 Accreditation Standards. This is based on a recent letter from the Committee on Accreditation of Canadian Medical Schools (CACMS) providing their decision on our March 2021 status report, as a follow-up from our CACMS accreditation visit in 2018. In addition, our University of Ottawa Skills and Simulation Centre has just received word from the Royal College that we are now considered to be fully adherent on all of its accreditation standards. Finally, our graduate programs in Cellular and Molecular Medicine (CMM), Neuroscience (NSC), Biochemistry (BCH) and Microbiology and Immunology (MIC) have also received within the last few months excellent reports on their cyclical reviews and numerous accolades from the expert external reviewers.
In the case of undergraduate medical education, our 2018 strong accreditation results have improved from the last report and now show that our consistent efforts toward excellence are bearing fruit. Just three elements – social accountability, career advising, and financial aid / debt management counseling / student educational debt – are designated as ‘satisfactory with monitoring’. Such improvements truly reflect our strategic efforts and investments of resources in specific areas to address previous concerns. Our current status is vividly illustrated in the colour-coded graphic presented below:
Overall, we can proudly say therefore that all of our educational programs are outstanding. This success nicely complements recent achievements on the research front that include, for example, higher success rates in CIHR grant competitions than the national average, $100M of CFI/ORF funding in the last five years, the Faculty leading a pan-Canadian research network to track COVID-19 variants through a $9M award from CIHR (with likely more funds to follow), and our success with several Faculty-specific programs such as the Clinical Research Chairs programs with investments of $40M over the next five years.
Altogether, these impressive achievements are important steps along the path toward our ambitious goal of becoming a Top 50 university worldwide for medicine and its related fields by our Faculty’s 80th anniversary in 2025. In line with our strategic plan Leading Innovation for a Healthier World, and with student satisfaction and the learning environment in mind, we also continue to expand our educational offerings and revitalize programs. For example, we are currently exploring the revitalization of our current programs and the creation of many new ones to meet our social accountability mandate and better serve our community. Among these, we are particularly proud of the recent University of Ottawa Senate approval of our new School of Pharmaceutical Sciences that will offer a PharmD program, thereby becoming Canada’s first French pharmacy program outside Quebec.
Congratulations are in order to all involved with these achievements with our educational programs and research initiatives. Together with significant progress with our other three strategic directions in Engagement, la Francophonie as well as with Internationalization and Global Health, our future is indeed bright and has never been so exciting!
Bernard Jasmin, PhD
Dean and Professor, Faculty of Medicine
University of Ottawa